Toward a Point-of-Need Bioluminescence-Based Immunoassay Utilizing a Complete Shelf-Stable Reagent

• Published in: Analytical chemistry (Washington) Vol. 93; no. 12; pp. 5177 - 5184
• Main Authors: Hall, Mary P, Kincaid, Virginia A, Jost, Emily A, Smith, Thomas P, Hurst, Robin, Forsyth, Stuart K, Fitzgerald, Connor, Ressler, Valerie T, Zimmermann, Kris, Lazar, Dan, Wood, Monika G, Wood, Keith V, Kirkland, Thomas A, Encell, Lance P, Machleidt, Thomas, Dart, Melanie L
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 30-03-2021
• Subjects: Analytical chemistry; Bioluminescence; Biomolecules; Chemistry; Complementation; Directed evolution; Format; Immunoassay; Immunoassays; Optimization; Peptides; Polypeptides; Reagents; Substrates; Thermal stability
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/acs.analchem.0c05074

Enzyme-linked immunosorbent assays (ELISAs) are used extensively for the detection and quantification of biomolecules in clinical diagnostics as well as in basic research. Although broadly used, the inherent complexities of ELISAs preclude their utility for straightforward point-of-need testing, where speed and simplicity are essential. With this in mind, we developed a bioluminescence-based immunoassay format that provides a sensitive and simple method for detecting biomolecules in clinical samples. We utilized a ternary, split-NanoLuc luciferase complementation reporter consisting of two small peptides (11mer, 13mer) and a 17 kDa polypeptide combined with a luminogenic substrate to create a complete, shelf-stable add-and-read assay detection reagent. Directed evolution was used to optimize reporter constituent sequences to impart chemical and thermal stability, as well as solubility, while formulation optimization was applied to stabilize an all-in-one reagent that can be reconstituted in aqueous buffers or sample matrices. The result of these efforts is a robust, first-generation bioluminescence-based homogenous immunoassay reporter platform where all assay components can be configured into a stable lyophilized cake, supporting homogeneous, rapid, and sensitive one-step biomolecule quantification in complex human samples. This technology represents a promising alternative immunoassay format with significant potential to bring critical diagnostic molecular detection testing closer to the point-of-need.